Siyu Deng Selected Research

Siyu Deng Research Topics

Disease

8	Neoplasms (Cancer) 12/2023 - 01/2018
6	Inflammation (Inflammations) 10/2023 - 01/2020
3	Bacterial Infections (Bacterial Infection) 01/2023 - 08/2021
2	Autoimmune Diseases (Autoimmune Disease) 01/2024 - 01/2022
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2023 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2023 - 12/2022
2	Osteoarthritis 06/2021 - 01/2021
1	Pathologic Processes 01/2024
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2024
1	Lymphatic Metastasis 10/2023
1	Neoplasm Metastasis (Metastasis) 10/2023
1	Stomach Neoplasms (Stomach Cancer) 10/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Sepsis (Septicemia) 01/2023
1	Triple Negative Breast Neoplasms 01/2023
1	Osteolysis 07/2022
1	Bone Resorption 07/2022
1	Wounds and Injuries (Trauma) 08/2021
1	Body Weight (Weight, Body) 08/2021
1	Necrosis 06/2021
1	Melanoma (Melanoma, Malignant) 05/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Lymphoma (Lymphomas) 01/2019
1	Cushing Syndrome 01/2018
1	ACTH-Secreting Pituitary Adenoma 01/2018
1	Pituitary ACTH Hypersecretion 01/2018

Drug/Important Bio-Agent (IBA)

4	Peptides (Polypeptides)IBA 01/2024 - 01/2022
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2022 - 01/2018
2	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2022
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 08/2021 - 02/2021
2	Vancomycin FDA LinkGeneric 08/2021 - 02/2021
1	MicropeptidesIBA 01/2024
1	Initiator Codon (Start Codon)IBA 01/2024
1	Olmesartan Medoxomil Drug Combination Amlodipine Besylate FDA Link 12/2023
1	Oxidoreductases (Dehydrogenase)IBA 12/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2023
1	Long Noncoding RNAIBA 10/2023
1	LipidsIBA 10/2023
1	Extracellular Matrix ProteinsIBA 10/2023
1	TenascinIBA 10/2023
1	AcidsIBA 01/2023
1	fibrin fragment D (D-dimer)IBA 01/2023
1	calcipotriene (calcipotriol)FDA LinkGeneric 01/2023
1	EnzymesIBA 01/2023
1	Fibrinogen (Factor I)FDA Link 01/2023
1	Immunoglobulin E (IgE)IBA 01/2023
1	LigandsIBA 01/2023
1	Metalloproteases (Metalloproteinases)IBA 01/2023
1	Glycoside Hydrolase InhibitorsIBA 01/2023
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2022
1	PropaneIBA 12/2022
1	Therapeutic UsesIBA 12/2022
1	Free RadicalsIBA 12/2022
1	Oxygen (Dioxygen)IBA 12/2022
1	corilaginIBA 07/2022
1	Interleukin-6 (Interleukin 6)IBA 08/2021
1	AntioxidantsIBA 08/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2021
1	safranine T (safranin)IBA 06/2021
1	Coloring Agents (Dyes)IBA 06/2021
1	Staphylococcal Protein A (Protein A)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	Polysaccharides (Glycans)IBA 01/2021
1	Pattern Recognition ReceptorsIBA 05/2020
1	FlavonoidsIBA 05/2020
1	QuercetinIBA 05/2020
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2020
1	Oxidants (Oxidizing Agents)IBA 05/2020
1	Interferon Type IIBA 05/2020
1	InterferonsIBA 05/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	PolyaminesIBA 01/2020
1	Urea (Carbamide)FDA LinkGeneric 01/2020
1	ArginaseIBA 01/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	histone deacetylase 3IBA 01/2019
1	B7-H1 AntigenIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	GlucocorticoidsIBA 01/2018
1	Deubiquitinating EnzymesIBA 01/2018
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2018
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2018
1	VemurafenibIBA 01/2018

Therapy/Procedure

3	Therapeutics 01/2023 - 01/2019
2	Immunotherapy 12/2022 - 01/2019